Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies

Kidney International

Volumn 87, Issue 3, 2015, Pages 602-609

  Vivarelli, Marina ^a   Emma, Francesco ^a   Pellé, Thimothée ^b,c   Gerken, Christopher ^d   Pedicelli, Stefania ^e   Diomedi Camassei, Francesca ^a   Klaus, Günter ^d   Waldegger, Siegfried ^d   Ronco, Pierre ^b,c   Debiec, Hanna ^b,c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL TENON   (France)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

antibodies; membranous nephropathy; neutral endopeptidase; pediatric nephrology; renal biopsy

Indexed keywords

ALLOANTIBODY; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; MEMBRANE METALLOENDOPEPTIDASE; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G;

ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CONFOCAL MICROSCOPY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; EDEMA; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; FETUS DEATH; GENE DELETION; GENETIC VARIABILITY; GESTATIONAL AGE; GLOMERULUS BASEMENT MEMBRANE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOALBUMINEMIA; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; INFANT; ITALIAN (CITIZEN); KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; MUTATIONAL ANALYSIS; NEPHROTIC SYNDROME; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; BLOOD; CLASSIFICATION; FETUS DISEASE; GENETICS; GLOMERULONEPHRITIS, MEMBRANOUS; HOMOZYGOTE; IMMUNOLOGY; NEWBORN; PREGNANCY; PREMATURITY;

FEMALE; FETAL DISEASES; GLOMERULONEPHRITIS, MEMBRANOUS; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; INFANT, PREMATURE; NEPRILYSIN; PREGNANCY; RENAL DIALYSIS;

EID: 84938416579     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.381     Document Type: Article

References (23)

1. Kerjaschki D. Pathogenetic concepts of membranous glomerulopathy (MGN). J Nephrol. 2000; 13: S96-S100
2. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis. 2010; 56: 157-167
3. Ronco P, Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol. 2012; 8: 203-213
4. Ronco P, Debiec H, Guigonis V. Mechanisms of disease: Alloimmunization in renal diseases. Nat Rev Nephrol. 2006; 2: 388-397
5. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002; 346: 2053-2060
6. Platt JL, Tucker WL, Michael AF. Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohematopoietic differentiation antigens. J Exp Med. 1983; 157: 155-172
7. Appay MD, Mounier F, Gubler MC, et al. Ontogenesis of the glomerular C3b receptor (CR1) in fetal human kidney. Clin Immunol Immunopathol. 1985; 37: 103-113
8. Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet. 2004; 364: 1252-1259
9. Ronco P, Pollard H, Galceran M, et al. Distribution of enkephalinase (membrane metalloendopeptidase, EC342411) in rat organs: detection using a monoclonal antibody. Lab Invest. 1988; 58: 210-217
10. Ronco P, Allegri L, Brianti E, et al. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology. Appl Pathol. 1989; 7: 85-98
11. Nortier JL, Debiec H, Tournay Y, et al. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr Nephrol. 2006; 21: 1399-1405
12. Turner AJ, Isaac RE, Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays. 2001; 23: 261-269
13. Hu P, Xuan Q, Hu B, et al. Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy. Mol Biol Rep. 2013; 40: 2963-2967
14. Dussaule JC, Stefanski A, Béa ML, et al. Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex. Am J Physiol. 1993; 264: F45-F52
15. Lu B, Figini M, Emanueli C, et al. The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med. 1997; 3: 904-907
16. Friedrich C, Endlich N, Kriz W, et al. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal Physiol. 2006; 291: F856-F865
17. Lewko B, Go"os M, Latawiec E, et al. Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones. J Physiol Pharmacol. 2006; 57: 599-610
18. Lebeau C, Debelle FD, Arlt VM, et al. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies. Nephrol Dial Transplant. 2005; 20: 2321-2332
19. Nambi P, Pullen M, Wu HL, et al. Down regulation of kidney neutral endopeptidase mRNA, protein and activity during acute renal failure: possible mechanism for ischemia-induced acute renal failure in rats?. Mol Cell Biochem. 1999; 197: 53-59
20. Ikeda K, Emoto N, Raharjo SB, et al. Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem. 1999; 274: 32469-32477
21. Bonvouloir N, Lemieux N, Crine P, et al. Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family. DNA Cell Biol. 2001; 20: 493-498
22. Aviv R, Gurbanov K, Hoffman A, et al. Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading. Kidney Int. 1995; 47: 855-860
23. Papandreou CN, Usmani B, Geng Y, et al. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgenindependent progression. Nat Med. 1998; 4: 50-57